FDA Recall
Terminated
Historical recordClass III
Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01
by SOMERSET THERAPEUTICS LLC
- Reason
- Failed Impurities/Degradation Specifications
- Published
- January 8, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15.
by AvKARE
- Reason
- Failed Dissolution Specifications
- Published
- January 8, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
RUSS DAVIS WHOLESALE
- Product
- Kowalski's Garden Salad Net Wt. 14oz. Keep Refrigerated. U…
- Reason
- Cucumbers have potential to be contaminated with Salmonella.
- Published
- January 8, 2025
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
RUSS DAVIS WHOLESALE
- Product
- Crazy Fresh Turkey Havarti Wrap, Net Wt 6.8oz. Keep Refrig…
- Reason
- Cucumbers have potential to be contaminated with Salmonella.
- Published
- January 8, 2025
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
RUSS DAVIS WHOLESALE
- Product
- Bacon Avocado Wrap, Net Wt 9.9oz. Keep Refrigerated. UPC…
- Reason
- Cucumbers have potential to be contaminated with Salmonella.
- Published
- January 8, 2025
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
RUSS DAVIS WHOLESALE
- Product
- Garden Salad w/Ranch Dressing, Net Wt 9oz. Keep Refrigerat…
- Reason
- Cucumbers have potential to be contaminated with Salmonella.
- Published
- January 8, 2025
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
RUSS DAVIS WHOLESALE
- Product
- Whole and Cut Cucumbers packaged in the following sizes: 1…
- Reason
- Cucumbers have potential to be contaminated with Salmonella.
- Published
- January 8, 2025
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
Sam'S Club
- Product
- Member's Mark Hatch Chile Chicken Enchiladas, ready to cook,…
- Reason
- Presence of Listeria monocytogenes
- Published
- January 8, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
Lithuanian Bakery, Inc.
- Product
- Chocolate Raspberry: Three sizes, 1. Small, Net Wt 1.25 lbs…
- Reason
- Products contain undeclared allergens (milk, soy, peanut, and wheat) and undeclared sulfites, yellow 5, yellow 6, and red 40)
- Published
- January 8, 2025
- Distribution
- Distributed to store front customers at…
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
Lithuanian Bakery, Inc.
- Product
- Napoleonas Torte packaged under the following sizes: 1. Sm…
- Reason
- Products contain undeclared allergens (milk, soy, and wheat) and undeclared sulfites, yellow 5, yellow 6.
- Published
- January 8, 2025
- Distribution
- Distributed to store front customers at…
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA
by RemedyRePack Inc.
- Reason
- CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Terminated
Historical recordClass II
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40
by Curium US, LLC
- Reason
- Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
by Breckenridge Pharmaceutical, Inc
- Reason
- CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
by Breckenridge Pharmaceutical, Inc
- Reason
- CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01
by Glenmark Pharmaceuticals Inc., USA
- Reason
- CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01
by Glenmark Pharmaceuticals Inc., USA
- Reason
- CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08
by Amerisource Health Services LLC
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04
by Amerisource Health Services LLC
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05
by Amerisource Health Services LLC
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04
by Amerisource Health Services LLC
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
View recall →
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions.
Read the full medical disclaimer.